112 related articles for article (PubMed ID: 33517812)
21. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
[No Abstract] [Full Text] [Related]
22. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
Tong Z; Meng X; Wang J; Wang L
Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
25. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
Wan P; Chen Z; Zhong W; Jiang H; Huang Z; Peng D; He Q; Chen N
Oncol Rep; 2020 Dec; 44(6):2475-2486. PubMed ID: 33125143
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
[TBL] [Abstract][Full Text] [Related]
27. Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
Liu X; Zhang D; Hao Y; Liu Q; Wu Y; Liu X; Luo J; Zhou T; Sun B; Luo X; Xu J; Wang Q; Yang Z; Li L
Cell Physiol Biochem; 2018; 46(6):2517-2531. PubMed ID: 29742507
[TBL] [Abstract][Full Text] [Related]
28. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
[TBL] [Abstract][Full Text] [Related]
29. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
Cui F; Luo P; Bai Y; Meng J
Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.
Pan Y; Wu Y; Hu J; Shan Y; Ma J; Ma H; Qi X; Jia L
Cell Prolif; 2018 Dec; 51(6):e12507. PubMed ID: 30105850
[TBL] [Abstract][Full Text] [Related]
31. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.
Xue S; Wang S; Li J; Guan H; Jiang S; Guo Y; Li Q
IUBMB Life; 2019 Nov; 71(11):1720-1728. PubMed ID: 31298469
[TBL] [Abstract][Full Text] [Related]
34. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
[TBL] [Abstract][Full Text] [Related]
35. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma.
Tian X; Zhang S; Zhang Q; Kang L; Ma C; Feng L; Li S; Li J; Yang L; Liu J; Qi Z; Shen Y
J Nutr Biochem; 2020 Nov; 85():108489. PubMed ID: 32827663
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.
Ma Z; Feng J; Guo Y; Kong R; Ma Y; Sun L; Yang X; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Cheng Y; Zha D; Liu S
Oncol Res; 2017 Jul; 25(6):887-895. PubMed ID: 28244855
[TBL] [Abstract][Full Text] [Related]
38. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
[TBL] [Abstract][Full Text] [Related]
39. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
40. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
